Emerald Health Therapeutics, Inc. EMHEMHTF has launched a new product line under the SYNC Wellness brand.
The SYNC Tab product line is the second of the company's Defined Dose products, and it expands its offering under its SYNC Wellness brand.
Fast dissolving tablets with 10 mg of THC each and predictable expected onset and offset come in cherry and mint flavors. Each pack has ten doses.
The sales are poised to commence on Tuesday, April 13. The new product line will be available in British Columbia, Manitoba, and Newfoundland, with Alberta to follow.
"Our product development efforts are centered on providing consumers with distinctive cannabis products offering controlled, predictable actions – with greater precision of dosing and the onset and offset of effects," the company's president and CEO Riaz Bandali said Tuesday.
"We have a talented product development team that is passionate about science and innovation. They are moving additional new product lines toward launches planned for the next few months and quarters, which we expect to start positively impacting our growth," he added.
Photo Source: Emerald Health Therapeutics
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.